Together we will beat cancer

Donate

Immunotherapy drug made available for some NHS patients with Hodgkin lymphoma

The immunotherapy drug pembrolizumab (Keytruda) can now be used to treat some patients with Hodgkin lymphoma on the NHS in England.

Read More

High-tech scans spare lymphoma patients intensive chemo

Hodgkin lymphoma patients can be spared the serious side effects of chemotherapy thanks to high-tech scans that can predict the outcome of treatment.

Read More

Cancer Research UK launches trial to fight cancer caused by a common virus

Cancer Research UK’s Drug Development Office (DDO) has launched a vaccine trial to treat some forms of cancer caused by the Epstein Barr Virus (EBV).

Read More

Developing a vaccine for the Epstein-Barr Virus could prevent up to 200,000 cancers globally say experts

A vaccine to prevent infection with a common herpes virus, the Epstein-Barr Virus (EBV), could help prevent 200,000 new cancers worldwide per year.

Read More

New radioactive drug shows impressive results in early Hodgkin’s lymphoma

TWO THIRDS of Hodgkin’s lymphoma patients treated with an experimental radioactive cancer therapy responded well to the treatment, reveal the results of a Cancer Research UK phase I trial published in Clinical Cancer Research*, today (Tuesday).

Read More

Non-Hodgkin lymphoma – more common but more curable

Cases of non-Hodgkin lymphoma have more than tripled in the last thirty years according to the latest Cancer Research UK figures published today.

Read More

Survivors of childhood Hodgkin’s Disease have increased risk of cancer

Children treated for Hodgkin’s disease before 1986 have an increased risk of developing another cancer later in life, according to a new study1 by an international team of researchers including scientists from Cancer Research UK.

Read More